Vivo Capital, LLC
47 holdingsFiling period: 2026-06-30Current AUM: $966.4Mestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | TRVI | Trevi Therapeutics Inc | 5.09M | $95.0M | $76.6M | 7.93% | -- | 2026-06-30 |
| 2 | PRAX | Praxis Precision Medicines | 271.1K | $90.8M | $84.8M | 8.78% | -67,779 | 2026-06-30 |
| 3 | ERAS | Erasca Inc | 4.13M | $75.6M | $67.1M | 6.94% | -8,024,068 | 2026-06-30 |
| 4 | AVBP | Arrivent BioPharma Inc | 1.68M | $58.4M | $47.0M | 4.87% | +796.2K | 2026-06-30 |
| 5 | ABVX | Abivax SA - ADR | 414.9K | $55.3M | $44.3M | 4.58% | +175.4K | 2026-06-30 |
| 6 | TNGX | Tango Therapeutics Inc | 1.38M | $43.1M | $33.0M | 3.41% | -775,011 | 2026-06-30 |
| 7 | CRVS | Corvus Pharmaceuticals Inc | 2.81M | $41.9M | $36.3M | 3.76% | -- | 2026-06-30 |
| 8 | DRUG | Bright Minds Biosciences Inc | 557.2K | $39.1M | $33.6M | 3.47% | -- | 2026-06-30 |
| 9 | — | Sinovac Biotech Ltd. | 5.90M | $38.2M | $38.2M | 3.95% | -- | 2026-06-30 |
| 10 | TENX | Tenax Therapeutics Inc | 2.50M | $36.4M | $4.6M | 0.47% | +2.29M | 2026-06-30 |
| 11 | ACRS | Aclaris Therapeutics, Inc. | 6.69M | $35.4M | $37.0M | 3.83% | +28.0K | 2026-06-30 |
| 12 | DYN | Dyne Therapeutics Inc | 1.56M | $34.6M | $27.9M | 2.88% | -- | 2026-06-30 |
| 13 | DNTH | Dianthus Therapeutics Inc | 354.0K | $34.5M | $37.1M | 3.84% | -- | 2026-06-30 |
| 14 | ANRO | Alto Neuroscience Inc | 1.21M | $31.9M | $36.6M | 3.78% | +173.3K | 2026-06-30 |
| 15 | DBVT | DBV Technologies SA | 1.84M | $30.3M | $21.7M | 2.24% | -822,811 | 2026-06-30 |
| 16 | SABS | SAB Biotherapeutics Inc | 7.30M | $28.5M | $24.9M | 2.58% | -4,120,091 | 2026-06-30 |
| 17 | MLTX | Moonlake Immunotherapeutics | 1.40M | $27.3M | $17.1M | 1.77% | +400.0K | 2026-06-30 |
| 18 | LBRX | LB Pharmaceuticals Inc | 800.0K | $26.0M | $34.4M | 3.56% | -- | 2026-06-30 |
| 19 | NERV | Minerva Neurosciences Inc | 4.32M | $24.0M | $16.6M | 1.71% | -- | 2026-06-30 |
| 20 | DSGN | Design Therapeutics Inc | 1.61M | $23.3M | $19.7M | 2.04% | -- | 2026-06-30 |
| 21 | ORIC | Oric Pharmaceuticals Inc | 1.85M | $20.0M | $22.9M | 2.36% | -- | 2026-06-30 |
| 22 | CAMP | CAMP4 Therapeutics Corporation | 4.25M | $18.6M | $17.8M | 1.84% | -- | 2026-06-30 |
| 23 | SNSE | Faeth Therapeutics Inc | 722.0K | $18.1M | $18.1M | 1.87% | -- | 2026-06-30 |
| 24 | ACHV | Achieve Life Sciences Inc. | 2.75M | $18.0M | $20.1M | 2.08% | -- | 2026-06-30 |
| 25 | CMPX | Compass Therapeutics Inc | 7.76M | $17.0M | $14.3M | 1.48% | -1,788,406 | 2026-06-30 |
← Scroll →
Page 1 of 2